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Background: Ganghwaljetongyeum (GHJTY), a complex herbal decoction, is used to treat rheumatoid arthritis.
However, the action mechanism of GHJTY is not still unclear on rheumatoid arthritis. In this study, we examined the
beneficial effects and the action mechanisms of GHJTY on synoviocyte proliferation and inflammatory mediators.
Methods: To test the effect of GHJTY on synoviocyte proliferation, HIG-82 cells, rabbit knee synovial membrane
cells, were treated with GHJTY under IL-1β. To evaluate the effects of GHJTY on proinflammatory mediators, we
tested cytokine levels in RAW264.7 cells.
Results: Proliferation of HIG-82 cells was significantly inhibited by GHJTY treatment. We found that GHJTY
caused cytoskeleton damage to HIG-82 cells. In contrast, treatment of GHJTY did not show any cytotoxicity to
other different origin cell lines, HeLa and RAW264.7 cells. GHJTY inhibited IL-1β-mediated NF-κB activation in
HIG-82 cells and reduced the LPS-mediated production of proinflammatory cytokines, TNF-α, IL-12, and NO in
RAW264.7 cells. In addition, the expression of cyclooxygenase in LPS-activated RAW264.7 cells was also
decreased by GHJTY treatment.
Conclusions: These results suggest that GHJTY might effectively attenuate rheumatoid arthritis by inhibiting the
production of proinflammatory mediators and the proliferation of synoviocytes.
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Rheumatoid arthritis is a chronic inflammatory disorder
accompanied by hyperplasia of the cartilage lining caused
by infiltration of inflammatory cells, ultimately resulting
in joint damage [1,2]. One of the most striking features
of inflammatory arthritis is hyperplasia of synovial
fibroblasts. Synovitis was reported to play an essential
role in the pathophysiology of rheumatoid arthritis [3,4].
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reproduction in any medium, provided the orproinflammatory cytokines and chemokines, and tumor
necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are
reported to be associated with the progression of rheuma-
toid arthritis [5]. In response to these cytokines, synovial
fibroblasts proliferate vigorously and form pannus tissues,
which destroy the cartilage and bone of the joints [6-8].
Nuclear factor-κB (NF-κB) is a transcription factor which
regulates gene expression associated with inflammation
and is strongly activated by a range of stimuli including
TNF-α, IL-1β, LPS, UV light, and oxidative stress [9].
Cyclooxygenase (COX) is strongly induced by IL-1β
and plays an important role in the pathophysiology of
rheumatoid arthritis [10]. Therefore, down-regulation
of proinflammatory cytokines and NF-κB may be anLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Prescription of GHJTY in daily doses





























Angelica gigas (Umbelliferae) 4 Korea
Hoelen Poria cocos (Polyporaceae) 4 China
Alismatis Rhizoma Alisma orientale
(Alismataceae)
4 Korea
Akebiae Caulis Akebia quinata
(Lardizabalaceae)
4 Korea
Citri Pericarpium Citrus unshiu (Rutaceae) 4 Korea
Chaenomelis Fructus Chaenomeles sinensis
(Rosaceae)
4 Korea
Phellodendri Cortex Phellodendron amurense
(Rutaceae)
3 China
Glycyrrhizae Radix Glycyrrhiza uralensis
(Leguminosae)
2 China
Juncus Medulla Juncus effuses (Juncaceae) 4 China
Gleditsiae Spina Gleditsia sinensis
(Leguminosae)
4 China
Lonicerae Caulis Lonicera japonica
(Caprifoliaceae)
4 China
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Antiproliferative agents that modulate synoviocyte growth
have been suggested to have potential as anti-rheumatic
drugs.
Pain-relieving and nonsteroidal anti-inflammatory drugs
(NSAIDs) can help to reduce pain and inflammation in
rheumatoid arthritis patients. New approach to the treat-
ment of rheumatoid arthritis has been concentrated to
develop safe and potent drugs. Some oriental medicines
[11-13] have been used to treat rheumatoid arthritis.
Curcumin, a natural product was reported to inhibit
inflammatory processes associated with arthritis [14].
Gangwhaljetongyeum (GHJTY), a traditional Korean herbal
medicine comprised with several component herbs (Table 1),
has been used to treat severe joint pain, limitation of
motion, fever, and swelling. In this study, we attempted
to evaluate the remedial value and the action mechan-
ism of GHJTY on rheumatoid arthritis by testing its
effect on the production of proinflammatory mediators
and the proliferation of synoviocytes.
Methods
Preparation of GHJTY extract
Herbal medicines used in this study were purchased from
Hwalim Natural Drug Co. Ltd (Busan, Korea) and the
origins were described in Table 1. The herbal formula of
GHJTY (Table 1) was extracted with hot distilled water
at 100°C for 2 hours at Dongshin University Oriental
Hospital (Gwangju, Korea). The extract was centrifuged
at 1,500 rpm for 20 min and the supernatant was
concentrated by evaporation under vacuum with preferably
low temperature (EYELA, Japan). The concentrated extract
was lyophilized by a vacuum freeze drier at −80°C (Samwon
Freezing Eengineering Co., Korea).
Cell cultures
A rabbit knee synovial membrane cell line, HIG-82
(American Type Culture Collection, Manassas, VA, USA),
was cultured in Ham’s F-12 nutrient mix medium (Ham’s
F-12, GIBCO, Invitrogen, Carlsbad, CA, USA) supplemented
with penicillin-streptomycin and 10% fatal bovine serum
(FBS, GIBCO, Invitrogen) under an atmosphere of 5%
CO2 in a humidified incubator. HeLa and RAW264.7 cells
(Korea Cell LineBank, Korea) were maintained in DMEM
(GIBCO, Invitrogen) and RPMI (GIBCO, Invitrogen),
respectively under above cell culture conditions.
Effect of GHJTY on cell proliferation
Cells seeded in a 96-well microplate (Corning, NY, USA)
at a density of 2 × 104 cells/well were cultured with or
without IL-1β (5 ng/ml) (Sigma-Aldrich, Saint Louis,
Missouri, USA). Celecoxib (Sigma-Aldrich) was used as a
control drug of arthritis. GHJTY or celecoxib was added to
the cells for 2 days. Cell proliferation was assayed using3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS), according to
manufacturer’s instructions (Promega, Madison, WI,
USA). Absorbance was read by an ELISA microplate
reader (Power Wavex340, NIO-TEK-INS TRUMENTS,
INC) at 490 nm. Proliferation was calculated as the
percentage (%) to not-treated cells.
Effect of GHJTY on actin cytoskeleton of HIG-82 cells
HIG-82 cells were seeded in an 8-well glass chamber
plate (Nalge Nunc International) at a density of 3 × 104
cells/well and cultured with or without IL-1β (5 ng/ml)
in Ham’s F-12 with 10% FBS for 2 days. After washing
with HBSS (GIBCO, Invitrogen), the cells were fixed in
3.7% formaldehyde for 15 min, permeabilized with 0.1%
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lution of Image iT signal enhancer (Molecular Probes,
Invitrogen) for 30 min. F actin was visualized by Alexa
Fluor 594-conjugated Phalloidin (Molecular Probes) as
described previously [15]. Confocal images of specimens
mounted with a ProLong gold antifade reagent with DAPI
(Molecular probes) were acquired using a laser scanning
confocal microscope (EZ-C1, Nikon).Effect of GHJTY on IL-1β-induced NF-κB transcription
activity in HIG-82 cells
HIG-82 cells seeded in a 96-well plate (Corning) at
1×104/well were transfected with a reporter plasmid,
pNF-κB-luciferase [16] using Hily Max (Dojindo, Japan).
One day after transfection, the cells were replaced with
fresh Ham’s F-12 containing different concentrations of
test agents and were incubated for 6 hours. The cells
were treated with lysis buffer (Promega) and luciferase
activities were assayed by a luminometer (MicroLumat
Plus LB96V; Berthold, Wilbad, Germany).Effect of GHJTY on the production of nitric oxide (NO)
and proinflammatory cytokines in RAW264.7 cells
RAW264.7 cells seeded at 1×105/well in a 48-well plate
(Corning) were preincubated with GHJTY or celecoxib
for 2 hours. LPS (Sigma) was added to the cells for
20 hours. The levels of cytokines, TNF-α and IL-12 were
measured in the cell supernatants using sandwich ELISA
kits following the manufacturer’s experimental protocols
(Biolegend, USA). Absorbance was read by an ELISA
microplate reader (Power Wavex340, NIO-TEK-INS
TRUMENTS, INC) at 450 nm. NO in the culture super-
natant was measured using Griess Reagent (0.1% N-(1-
naphthyl)-ethylendiamine dihydrochoride, 1% Sulfanila-
mide in 2.5% H3PO4).Figure 1 GHJTY specifically inhibits the proliferation of HIG-82
cells. (A) HIG-82 cells were exposed to IL-1β or GHJTY for 2 days
and cell proliferation was assayed by MTS. Proliferation of HIG-82Effect of GHJTY on the expression of COX in LPS-activated
RAW264.7 cells
RAW264.7 cells were cultured in a 6-well plate (Corning,
USA) at 1×106/well overnight. GHJTY or celecoxib was
pretreated to the cells for 2 hours and LPS (1 μg/ml) was
added for 18 hours. COX protein was detected by Western
blot analysis using an antibody specific to COX-1 (Santa
Cruz, USA) and a detection kit, Immobilon Western
(Millipore, USA). The relative amount of COX-1 protein
was analyzed by LAS-4000 mini (Fujifilm, Japan).cells was decreased by Celecoxib (Cel). GHJTY significantly reduced
the proliferation of HIG-82 cells at concentrations of 0.3 to 1.0 mg/ml.
GHJTY did not show any cytotoxic effect on other origin cells, HeLa
and RAW264.7 cells (B and C). ++ P < 0.01: compared with non-treated
group, * P < 0.05, ** P < 0.01, and *** P < 0.001: compared with IL-1β
treated group.Statistical analyses
The results are expressed as mean ± SEM unless otherwise
stated. Statistical differences were evaluated using Student's
t-test, with a P value < 0.05 considered significant.Results and discussion
GHJTY suppresses the proliferation of HIG-82 cells
To assess the effect of GHJTY on synoviocyte proliferation,
HIG-82 cells were exposed to IL-1β and GHJTY for 2 days.
Cell proliferation was assayed by MTS. IL-1β caused
proliferation of HIG-82 cells, which was inhibited by
Celecoxib, a non-steroidal anti-inflammatory drug used
for the treatment of rheumatoid arthritis. GHJTY signifi-
cantly suppressed the proliferation of HIG-82 cells at
concentrations of 0.3 and 1.0 mg/ml (Figure 1A). In
contrast, GHJTY did not show any cytotoxic effect on
other origin cells, HeLa and RAW264.7 cells (Figure 1B
Figure 2 GHJTY causes the rearrangement of actin cytoskeleton in HIG-82 cells. HIG-82 cells were treated with GHJTY for 2 days and actin
and nucleus were stained with Alexa Fluor 594-conjugated Phalloidin (red color) and DAPI (blue color), respectively. GHJTY caused the disruption
of actin filament in HIG-82 cells and the nuclei of the cells to be condensed. The effect of GHJTY was also shown in IL-1β-activated HIG-82 cells.
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cytotoxic activity to synoviocyte HIG-82 cells.GHJTY causes rearrangement of actin cytoskeleton of
HIG-82 cells
While studying the cytotoxic effect of GHJTY on HIG-
82 cells, we found that the dying cells became rounded
and shrunk. To visualize the morphologic changes of
HIG-82 cells, actin and nucleus were stained with Alexa
Fluor 594-conjugated Phalloidin and DAPI, respectively.
GHJTY caused disruption of actin filaments in HIG-82
cells (Figure 2). Nuclei of HIG-82 cells treated with
GHJTY were shown to be condensed (Figure 2). The ef-
fect of GHJTY was also shown in IL-1β-activated HIG-
82 cells (Figure 2).Figure 3 GHJTY reduces the IL-1β-induced NF-κB activation in
HIG-82 cells. HIG-82 cells were transfected with a reporter plasmid,
pNF-κB-luciferase. IL-1β increased NF- κB transcription, which was
blocked by GHJTY at a concentration of 1.0 mg/ml. Celecoxib (Cel)
also blocked IL-1β-induced NF-κB activation in HIG-82 cells. * P < 0.05
and ** P < 0.01: compared with IL-1β treated group.GHJTY suppresses IL-1β-induced NF-κB activation in
HIG-82 cells
NF-κB is a transcription factor involved in inflammation
and arthritis. The effect of GHJTY was tested on NF-κB
activation in HIG-82 cells. IL-1β increased NF-κB tran-
scription, which was blocked by GHJTY at a concentra-
tion of 1.0 mg/ml (Figure 3). Celecoxib also blocked the
IL-1β-induced NF-κB activation in HIG-82 cells.GHJTY inhibits LPS-induced production of NO, TNF-α, and
IL-12 in RAW264.7 cells
To study the effect of GHJTY on the production of
inflammatory mediators, RAW264.7 cells were pretreated
with GHJTY for 2 hours and then incubated with LPS for
20 hours. The LPS-induced NO production in RAW264.7
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(Figure 4A). In addition, inflammatory cytokines were
measured in the cell supernatants by ELISA. GHJTY
partly decreased the LPS-induced production of TNF-α
and IL-12 cytokines (Figure 4B and 4C).GHJTY suppresses the COX-1 expression in LPS-activated
RAW264.7 cells
To study the effect on COX-1 expression, GHJTY
was treated to the cells for 2 hours and LPS was
added for 18 hours. LPS induced COX-1 expression,Figure 4 GHJTY decreases the LPS-increased production of NO,
TNF-α, and IL-12 in RAW264.7 cells. RAW264.7 cells were
pretreated with GHJTY for 2 hours and then incubated with LPS for
18 hours. (A) LPS-induced NO production in RAW264.7 cells was
blocked by GHJTY pretreatment. Inflammatory cytokines were
measured in the cell supernatants by ELISA. GHJTY decreased the
LPS-induced production of TNF-α (B) and IL-12 (C) cytokines. ++
P < 0.01 and +++ P < 0.001: compared with non-treated group,
* P < 0.05, ** P < 0.01, and *** P < 0.001: compared with LPS-treated
group.which was reduced by treatment of Celecoxib, a COX
inhibitor (Figure 5). GHJTY suppressed the expres-
sion of COX-1 in LPS-activated RAW264.7 cells
(Figure 5).Conclusion
Rheumatoid arthritis is an autoimmune disease charac-
terized by synovial proliferation, infiltration of lym-
phocytes and macrophage into the synovial lining, and
a paucity of apoptosis [6]. We evaluated the remedial
value of GHJTY, a prescription for rheumatoid arth-
ritis, by examining its effect on synoviocyte prolif-
eration and inflammatory responses. First, GHJTY
significantly inhibited the proliferation of HIG-82 cells,
a rabbit knee synovial membrane cell line (Figure 1A)
by causing cytoskeleton damage to the cells (Figure 2).
In contrast, GHJTY did not show any cytotoxic effects
on other origin cell lines, HeLa and RAW264.7 cells
(Figure 1B and 1C). In addition to the inhibitory effect
on synoviocyte growth, GHJTY reduced the IL-1β-
mediated NF-κB activation in HIG-82 cells (Figure 3).
Moreover, GHJTY decreased the LPS-mediated pro-
duction of proinflammatory cytokines, TNF-α, IL-12,
and NO in RAW264.7 cells (Figure 4A, 4B, and 4C).
The expression of COX-1 in LPS-activated RAW264.7
cells was also reduced by GHJTY treatment (Figure 5).
Consequently, GHJTY was shown to be effective in
decreasing the hyperplasia of synovial fibroblasts and
inflammatory responses, the most striking features of
inflammatory arthritis. These results suggest that
GHJTY might effectively attenuate rheumatoid arth-
ritis by inhibiting the production of proinflammatory
mediators from macrophage-like cells and the
proliferation of synoviocytes.LPS        - +               +                +
Cel - - +                 -
GHJTY          - - - +
AU/mm2 1.0          6.0 4.0 4.5
β-actin
COX-1
Figure 5 GHJTY reduces the expression of COX-1 in LPS-activated
RAW264.7 cells. RAW264.7 cells were pretreated with GHJTY for
2 hours and LPS was added to the cells for 18 hours. β-actin was
used as a control protein. COX-1 was detected by Western blot
analysis and the relative amounts were described as AU/mm2.
Celecoxib (Cel) and GHJTY reduced the expression of COX-1 in
LPS-activated RAW264.7 cells.
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